Advisor Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Advisor Group’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,262	Closed	-$5K	–	4825
2016 Q3	$5K	Sell	15,262 -2,500	-14%	-$819	﹤0.01%	3953
2016 Q2	$8K	Buy	+17,762	New	+$8K	﹤0.01%	3615

Advisor Group's RXII Position: Q4 2016 in Review

Advisor Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 15,262 shares — an estimated $5K sold.

Advisor Group first reported a position in RXII in Q2 2016 and held it in 2 quarters. The position peaked at $8K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Advisor Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Advisor Group sold 15,262 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $5K.
Advisor Group first reported a position in GALENA BIOPHARMA INC COM in Q2 2016 and held it in 2 quarters.
Advisor Group's GALENA BIOPHARMA INC COM position peaked at $8K in Q2 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Advisor Group's 13F filing for Q4 2016, filed 31 Jan 2017.